Manage pretransplant and posttransplant patients  Screen donors and recipient for COVID‐19
Do not postpone transplants (an essential medical service, CMS Tier 3b)
Notify patients of possible extended waiting times on transplant list
Have low threshold for admitting patients on transplant waiting list diagnosed with COVID‐19
For posttransplant patients with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate
Do not reduce immunosuppressive therapy in patients with mild COVID‐19 disease  Test donors and recipient for COVID‐19
Limit transplant listing to emergency and urgent cases
Look for SARS‐COV‐2 prior to organ procurement; defer donors with evidence of infection
Consider specific COVD‐19 consent for patients on transplant waiting list
For posttransplant patient with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate
Do not reduce immunosuppressive therapy in patients with mild COVID‐19 disease  Maintain care per guidelines
Limit transplantation listings to patients with poor short‐term prognosis
Vaccinate against pneumonia and flu
Avoid reductions in immunosuppressive therapy
Do not reduce immunosuppressive therapy in patients with mild COVID‐19